All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
Introducing
Now you can personalise
your PsOPsA Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB and Bristol Myers Squibb: For educational content and news updates.
During The European Congress of Rheumatology (EULAR) 2023, the Psoriasis and Psoriatic Arthritis Hub was pleased to speak with Barbra Bohannan, Swedish Psoriasis Association, Stockholm, SE. We asked about insights on living with psoriatic disease.
Living with psoriatic disease
Bohannan discusses the challenges she has faced while dealing with psoriatic arthritis, including comorbidities, stress, and environmental factors. She goes on to discuss the importance of considering the factors influencing treatment outcomes, such as age, gender, and disease severity. Finally, Bohannan discusses the most effective ways to approach difficult topics with patients, and describes how communication is imperative for a better understanding of disease progression and ultimately, improved treatment outcomes.
Your opinion matters
Subscribe to get the best content related to Psoriasis and Psoriatic Arthritis delivered to your inbox